Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacodynamic studies of taniborbactam (VNRX-5133) combined with cefepime against β-lactamase–producing Gram-negative bacteria in a neutropenic murine thigh infection model

Journal of Antimicrobial Chemotherapy(2025)10.1093/jac/dkaf431Source: DataRank Database

Pharmacodynamic studies of taniborbactam (VNRX-5133) combined with cefepime against β-lactamase–producing Gram-negative bacteria in a neutropenic murine thigh infection model is a research paper published in Journal of Antimicrobial Chemotherapy (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 0.68)OA: hybridTopics (51)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Maria Siopi ORCID,Marilena Tsala,Claudia Lagarde,Wendy Kloezen,Anouk E Muller

Live enrichment

PubMed:41533743 PMC:PMC12802961 OpenAlex:https://openalex.org/W7124318207

Department of Health and Human Services

Grant: HHSN272201300019C

Wellcome Trust

Grant: WT101999/Z/13/Z

NIAID NIH HHS

Grant: HHSN272201300019I

National Institute of Allergy and Infectious Diseases

NIH HHS

Wellcome Trust

VenatoRx Pharmaceuticals Inc.

National Institute of Allergy and Infectious Diseases

VenatoRx Pharmaceuticals Inc.

NIH HHS

Wellcome Trust

FWCI

0.68

Citation Percentile

0.7%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1093/jac/dkaf431

publisherhttps://doi.org/10.1093/jac/dkaf431

publisherhttps://academic.oup.com/jac/article-pdf/81/1/dkaf431/65780262/dkaf431.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41533743

repositoryhttps://pure.eur.nl/en/publications/ccafcfd4-2618-4db6-8856-7bff3419d540

Fields of Study

Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyNosocomial Infections in ICUAnimalsCefepimeMicrobial Sensitivity TestsMiceAnti-Bacterial AgentsNeutropeniabeta-LactamasesDisease Models, AnimalPseudomonas aeruginosabeta-Lactamase InhibitorsBorinic AcidsFemaleDrug Therapy, CombinationThird Generation CephalosporinsBoronic AcidsEnterobacteriaceaeGram-Negative BacteriaGram-Negative Bacterial InfectionsEnterobacteriaceae InfectionsCarboxylic Acids

MeSH Terms

CefepimeThird Generation CephalosporinsAnimalsAnti-Bacterial Agentsbeta-LactamasesBorinic AcidsBoronic AcidsCarboxylic AcidsCephalosporinsDisease Models, AnimalDrug Therapy, CombinationEnterobacteriaceaeEnterobacteriaceae InfectionsFemaleGram-Negative BacteriaMicrobial Sensitivity TestsNeutropeniaPseudomonas aeruginosaThighGram-Negative Bacterial InfectionsMicebeta-Lactamase Inhibitors

Keywords

CefepimeBacteriaPharmacodynamicsAntibacterial agentAntibioticsThigh